期刊文献+

麝香保心丸通过上调20-HETE调控内皮祖细胞促进心肌梗死大鼠血管新生 被引量:4

Shexiang Baoxin Pill Promotes Angiogenesis after Myocardial Infarction via 20-HETE Regulated-endothelial progenitor cells Mobilization in Rats
下载PDF
导出
摘要 目的:通过建立大鼠心肌梗死模型,探讨麝香保心丸(Shexiang Baoxin Pill,SBP)促进血管新生的效应和相关机制。方法:通过结扎冠脉前降支构建大鼠心肌梗死模型并给予SBP及20-HETE特异性合成抑制剂(HET0016)干预8周,观察心梗后心脏结构和功能、梗死交界区VEGF的变化及循环血中内皮祖细胞(endothelial progenitor cells,EPCs)的数量、20-HETE的变化。结果 :SBP可上调心梗后大鼠循环血中的20-HETE(0.35±0.02vs.0.56±0.04 ng/ml,P<0.05),有助于提高心梗后心脏射血分数[(46.3±4.20%vs.(62.30±3.40)%,P<0.05],增加梗死交界区VEGF(3.50±0.50 vs.9.80+1.00,P<0.05)及循环血中的EPCs的数量(0.16±0.06 vs.0.38±0.09,P<0.05),20-HETE特异性抑制剂可阻断SBP的效应。结论 :SBP可通过20-HETE调控EPCs促进血管新生。 Objective:The present study was to explore whether Shexiang Baoxin Pill(SBP) could promote angiogenesis through 20-HETE mediated-endothelial progenitor cells(EPCs) mobilization in a rat model of myocardial infarct.Methods: Experimental myocardial infarction(MI) model was established in rats via occlusion of the left anterior descending coronary artery. SBP and a specific inhibitor of 20-HETE biosynthesis(HET0016) were administrated for eight weeks after MI surgery. Cardiac function was evaluated by echocardiography. The changes of VEGF in the border area of MI were measured. 20-HETE and EPCs in the circulating blood were detected. Results :SBP improved the heart ejection fraction [(46.3 ±4.20)% vs.(62.30 ±3.40)%, P〈0.05 ] after MI, increased VEGF(3.50 ±0.50 vs.9.80 +1.00, P〈0.05) and EPCs(0.16 ±0.06 vs. 0.38 ±0.09, P〈0.05) in the border area of MI 20-HETE biosynthesis inhibitor can block effect of SBP. Conclusion : SBP can promote angiogenesis by 20-HETE regulatedEPC smobilization.
出处 《岭南急诊医学杂志》 2016年第1期4-6,24,共4页 Lingnan Journal of Emergency Medicine
基金 国家自然科学基金(81370837 81170647) 中国中西医结合学会-和黄科研基金(2013002)
关键词 麝香保心丸 20-HETE 内皮祖细胞 血管新生 Shexiang Baoxin Pill 20-HETE endothelial progenitor cells angiogenesis
  • 相关文献

参考文献7

  • 1Mozaffarian D, Benjamin E J, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association [J]. Circulation, 2015, 131(4)- e29.
  • 2Kirton JP, Xu Q. Endothelial precursors in vascular repair [J]. Microvasc Res, 2010, 79(3): 193.
  • 3Jarajapu YP, Grant MB. The promise of cell-based therapies for diabetic complications: challenges and solutions [J]. Circ Res, 2010, 106(5): 854.
  • 4Guo AM, Arbab AS, Falck JR, et al. Activation of vascular endothelial growth factor through reactive oxygen Species mediates 20 - hydroxyeicosatetraenoic acid-induced endothelial cell proliferation [J]. J Pharmacol Exp Ther, 2007, 321 (1): 18.
  • 5Josko J, Gwozdz B, Jedrzejowska-Szypulka H, et al. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis [ J ]. Med Sci Monit, 2000, 6 (5) : 1047.
  • 6Guo AM, Janic B, Sheng J, et al. The cytochromeP450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood EJ]. J Pharmacol Exp Ther, 2011, 338(2): 421.
  • 7Li B, Sharpe EE, Maupin AB, et al. VEGF and P1GF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization [J]. FASEB J, 2006, 20(9) : 1495.

同被引文献100

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部